(2Z)-2-(nitromethylidene)-3-phenyl-1,3-thiazolidin-4-one

Compound number
MolPort-002-867-442
CAS number
1164508-39-7
IUPAC
(2Z)-2-(nitromethylidene)-3-phenyl-1,3-thiazolidin-4-one
IUPAC traditional
(2Z)-2-(nitromethylidene)-3-phenyl-1,3-thiazolidin-4-one
SMILES
[O-][N+](=O)\C=C1/SCC(=O)N1c1ccccc1
InChI key
WZAJGYJJKCRCCZ-POHAHGRESA-N
Molecular formula
Molecular weight
236.25
DMSO Solubility
Not known

Marketplace Offers

BIONET - Key Organics Ltd.

Direct S&H to USA:
80.00 USD
Catalog
Screening compound
Ships out
10 business days
Purity
90%
Last updated
today
In warehouse
11.25 g

Supplier Catalogue Data

Pack size Ships out Price Quantity
1 mg October 19, 2022 40.00 USD
Add to Cart Buy
2 mg October 19, 2022 46.00 USD
Add to Cart Buy
3 mg October 19, 2022 47.00 USD
Add to Cart Buy

BIONET - Key Organics Ltd.

Direct S&H to USA:
80.00 USD
Catalog
Building blocks
Ships out
10 business days
Purity
90%
Last updated
today
In warehouse
11.25 g

Supplier Catalogue Data

Pack size Ships out Price Quantity
1 mg October 19, 2022 40.00 USD
Add to Cart Buy
5 mg October 19, 2022 50.00 USD
Add to Cart Buy
10 mg October 19, 2022 69.00 USD
Add to Cart Buy

Get your compounds in the right format

Molport Reweighting and Reformatting Services

More Information

Compound identifiers

Compound number
MolPort-002-867-442
CAS number
1164508-39-7

Names, Synonyms and 3rd Party Identifiers

Name
2-(nitromethylene)-3-phenyl-,3-thiazolan-4-one
MFCD01935899

InChI

InChI
1/C10H8N2O3S/c13-9-7-16-10(6-11(14)15)12(9)8-4-2-1-3-5-8/h1-6H,7H2/b10-6-
InChI key
WZAJGYJJKCRCCZ-POHAHGRESA-N

Formula

Molecular formula
C10H8N2O3S
Molecular weight
236.25

Molport Guarantee

When you purchase products through the Molport website from any seller other than Molport itself, you will be protected by the Molport Guarantee. If you purchase products from Molport itself, this Molport Guarantee will not apply, and your remedies will be governed by the Molport Terms of Sale and Supply.

We use cookies to improve your experience on our websites and for advertising. By clicking "Accept All", you consent to our use of cookies. Learn more.

Feedback